Annual Cash & Cash Equivalents
$672.30 M
-$84.87 M-11.21%
31 December 2023
Summary:
GoodRx Holdings annual cash & cash equivalents is currently $672.30 million, with the most recent change of -$84.87 million (-11.21%) on 31 December 2023. During the last 3 years, it has fallen by -$296.39 million (-30.60%). GDRX annual cash & cash equivalents is now -30.60% below its all-time high of $968.69 million, reached on 31 December 2020.GDRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$423.78 M
-$101.13 M-19.27%
30 September 2024
Summary:
GoodRx Holdings quarterly cash and cash equivalents is currently $423.78 million, with the most recent change of -$101.13 million (-19.27%) on 30 September 2024. Over the past year, it has dropped by -$371.13 million (-46.69%). GDRX quarterly cash and cash equivalents is now -60.58% below its all-time high of $1.08 billion, reached on 30 September 2020.GDRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -46.7% |
| 3 y3 years | -30.6% | -53.5% |
| 5 y5 years | +1843.0% | - |
GDRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.6% | at low | -55.0% | at low |
| 5 y | 5 years | -30.6% | +2480.8% | -60.6% | +1526.8% |
| alltime | all time | -30.6% | +2480.8% | -60.6% | +1526.8% |
GoodRx Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $423.78 M(-19.3%) |
| June 2024 | - | $524.90 M(-1.6%) |
| Mar 2024 | - | $533.29 M(-20.7%) |
| Dec 2023 | $672.30 M(-11.2%) | $672.30 M(-15.4%) |
| Sept 2023 | - | $794.90 M(+4.3%) |
| June 2023 | - | $761.99 M(+0.1%) |
| Mar 2023 | - | $761.08 M(+0.5%) |
| Dec 2022 | $757.16 M | $757.16 M(+3.9%) |
| Sept 2022 | - | $728.79 M(-0.2%) |
| June 2022 | - | $730.54 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $845.43 M(-10.2%) |
| Dec 2021 | $941.11 M(-2.8%) | $941.11 M(+3.2%) |
| Sept 2021 | - | $912.02 M(+1.9%) |
| June 2021 | - | $894.70 M(-9.7%) |
| Mar 2021 | - | $990.46 M(+2.2%) |
| Dec 2020 | $968.69 M(+3618.6%) | $968.69 M(-9.9%) |
| Sept 2020 | - | $1.08 B(+749.0%) |
| June 2020 | - | $126.63 M(+386.1%) |
| Dec 2019 | $26.05 M(-24.7%) | $26.05 M |
| Dec 2018 | $34.60 M | - |
FAQ
- What is GoodRx Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GoodRx Holdings?
- What is GoodRx Holdings annual cash & cash equivalents year-on-year change?
- What is GoodRx Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GoodRx Holdings?
- What is GoodRx Holdings quarterly cash and cash equivalents year-on-year change?
What is GoodRx Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of GDRX is $672.30 M
What is the all time high annual cash & cash equivalents for GoodRx Holdings?
GoodRx Holdings all-time high annual cash & cash equivalents is $968.69 M
What is GoodRx Holdings annual cash & cash equivalents year-on-year change?
Over the past year, GDRX annual cash & cash equivalents has changed by -$84.87 M (-11.21%)
What is GoodRx Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GDRX is $423.78 M
What is the all time high quarterly cash and cash equivalents for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash and cash equivalents is $1.08 B
What is GoodRx Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, GDRX quarterly cash and cash equivalents has changed by -$371.13 M (-46.69%)